X. Zhao

发表

1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.

D. Peehl, N. Navone, D. Feldman, 2000, Endocrinology.

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

D. Peehl, N. Navone, D. Feldman, 1999, The Journal of urology.

Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.

D. Feldman, X. Zhao, David Feldman, 1993, Endocrinology.

Negative autoregulation of the neu gene is mediated by a novel enhancer

M. Hung, X. Zhao, 1992, Molecular and cellular biology.

Amplification of the proto-neu oncogene facilitates oncogenic activation by a single point mutation.

M. Hung, D. Yan, X. Zhao, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.

D. Feldman, L. Holloway, X. Zhao, 1999, Endocrinology.

1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.

D. Peehl, D. Feldman, X. Zhao, 1997, Endocrinology.

Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo.

R. Bouillon, L. Verlinden, A. Verstuyf, 2000, Cancer research.

Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells.

D. Peehl, D. Feldman, X. Zhao, 1999, Endocrinology.

Oestrogen-binding protein in Candida albicans: antibody development and cellular localization by electron immunocytochemistry.

C. Ardies, P. Malloy, D. Feldman, 1995, Microbiology.

Cloning and expression of the gene from Candida albicans that encodes a high-affinity corticosteroid-binding protein.

P. Malloy, D. Feldman, X. Zhao, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.

J. Roth, M. Hung, J. Manning, 1989, Cancer research.

Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1.

P. Cohen, D. Feldman, Xiao-yan Zhao, 2001, The Journal of urology.

Vitamin D and prostate cancer.

D. Peehl, D. Feldman, A. Krishnan, 1995, Advances in experimental medicine and biology.

Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.

D. Feldman, X. Zhao, C. Gross, 1997, Molecular endocrinology.

A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.

W. Zhu, P. Malloy, D. Feldman, 2001, Molecular genetics and metabolism.

PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression.

G. Reaven, P. Malloy, D. Feldman, 1999, Biochemical and biophysical research communications.

The role of vitamin D in prostate cancer.

D. Peehl, D. Feldman, A. Krishnan, 2001, Steroids.